In melanoma (Neef et al., 2002), breast cancer (Nagai et al., 2007), oral cancer (Coutinho-Camillo et al., 2013), and stomach cancers (Zhao et al., 2015), the reduced expression of PHLDA1 has already been described. This evidence concerns the gene PHLDA1 and lip and oral cavity carcinoma.